ArticleInternational journal of molecular sciences2025

The Combination Empagliflozin/Metformin Attenuates the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease in a Diet-Induced Experimental Rat Model.

Oscar René Zambrano-Vásquez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.